ArticleBMJ open2022

ImmunoSep (Personalised Immunotherapy in Sepsis) international double-blind, double-dummy, placebo-controlled randomised clinical trial: study protocol.

Antigone Kotsaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.